Sanofi Investments

Sanofi has invested in 24 companies and its latest investment was Enveda Biosciences on Feb 25, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Enveda Biosciences is a Colorado-based biotechnology company that provides plant-powered drug discovery and development solutions for the pharmaceutical sector.
$20M
Feb 25, 2025
-
Zucara is a Canada-based pre-clinical life science company that researches and develops drug therapies to treat hypoglycemia in patients with diabetes.
$20M
Nov 11, 2024
-
Resalis is an Italy-based biotechnology company that develops non-coding RNA therapies for the treatment of metabolic disorders.
-
Oct 27, 2024
-
AgomAb is a Belgium-based biotechnology company that researches and develops novel therapies and agonistic antibodies for the treatment of organ failure and fibrotic diseases.
$89M
Oct 24, 2024
-
$326M
Oct 16, 2024
-

Frequently Asked Questions about Sanofi

  1. What is Sanofi investing in?

    Sanofi has invested in 24 companies including Enveda Biosciences, Zucara and Resalis
  2. What company did Sanofi invest in?

    Sanofi invested in a total 24 companies including Enveda Biosciences, Zucara and Resalis
  1. What are the top 5 investments by Sanofi?

    The top companies in which Sanofi invested are Enveda Biosciences, Zucara, Resalis, Agomab and Orano Med